Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cost-Benefit Analysis | 28 | 2024 | 5536 | 1.210 |
Why?
|
Technology Assessment, Biomedical | 6 | 2024 | 312 | 1.000 |
Why?
|
Medical Records Systems, Computerized | 24 | 2005 | 1196 | 0.900 |
Why?
|
Muscular Dystrophy, Duchenne | 2 | 2024 | 271 | 0.880 |
Why?
|
United States Food and Drug Administration | 3 | 2024 | 1673 | 0.550 |
Why?
|
Models, Economic | 8 | 2021 | 719 | 0.540 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2019 | 260 | 0.530 |
Why?
|
Evidence-Based Medicine | 10 | 2017 | 3706 | 0.430 |
Why?
|
Confidentiality | 9 | 1998 | 607 | 0.410 |
Why?
|
Dystrophin | 2 | 2024 | 284 | 0.370 |
Why?
|
Prediabetic State | 1 | 2016 | 548 | 0.360 |
Why?
|
Comparative Effectiveness Research | 3 | 2024 | 714 | 0.350 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2021 | 12252 | 0.340 |
Why?
|
Glucagon-Like Peptides | 2 | 2021 | 157 | 0.320 |
Why?
|
Hemophilia A | 2 | 2023 | 359 | 0.310 |
Why?
|
Practice Guidelines as Topic | 13 | 2017 | 7454 | 0.280 |
Why?
|
Asthma | 2 | 2022 | 6291 | 0.250 |
Why?
|
Computer Communication Networks | 6 | 1998 | 295 | 0.250 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 430 | 0.240 |
Why?
|
Drug Costs | 6 | 2024 | 1195 | 0.240 |
Why?
|
Factor IX | 1 | 2024 | 76 | 0.230 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 620 | 0.230 |
Why?
|
Hemophilia B | 1 | 2024 | 83 | 0.220 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 2024 | 44 | 0.220 |
Why?
|
Quality-Adjusted Life Years | 7 | 2022 | 1741 | 0.210 |
Why?
|
Retinal Diseases | 2 | 2019 | 710 | 0.210 |
Why?
|
Reminder Systems | 5 | 1996 | 388 | 0.210 |
Why?
|
Needle-Exchange Programs | 1 | 2022 | 27 | 0.200 |
Why?
|
Dermatitis, Atopic | 2 | 2022 | 737 | 0.200 |
Why?
|
Review Literature as Topic | 2 | 2017 | 297 | 0.200 |
Why?
|
Cost Savings | 3 | 2024 | 904 | 0.200 |
Why?
|
Mass Screening | 2 | 2017 | 5458 | 0.200 |
Why?
|
BCG Vaccine | 2 | 2022 | 381 | 0.190 |
Why?
|
Drug Approval | 3 | 2024 | 821 | 0.190 |
Why?
|
Drug Therapy, Computer-Assisted | 2 | 1994 | 198 | 0.180 |
Why?
|
Diabetic Retinopathy | 1 | 2010 | 1300 | 0.180 |
Why?
|
Treatment Outcome | 19 | 2024 | 65379 | 0.180 |
Why?
|
Antipsychotic Agents | 2 | 2024 | 3081 | 0.180 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2020 | 42 | 0.180 |
Why?
|
Pregnenediones | 1 | 2020 | 29 | 0.170 |
Why?
|
Computer Systems | 6 | 1997 | 469 | 0.170 |
Why?
|
beta-Thalassemia | 1 | 2022 | 234 | 0.170 |
Why?
|
Online Systems | 2 | 2001 | 182 | 0.170 |
Why?
|
United States | 20 | 2024 | 73039 | 0.170 |
Why?
|
Receptors, Serotonin | 1 | 2020 | 211 | 0.170 |
Why?
|
Humans | 79 | 2024 | 768171 | 0.170 |
Why?
|
Anti-Obesity Agents | 1 | 2023 | 240 | 0.160 |
Why?
|
California | 2 | 2023 | 1438 | 0.160 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2022 | 2195 | 0.160 |
Why?
|
Evaluation Studies as Topic | 4 | 1997 | 1627 | 0.160 |
Why?
|
Guideline Adherence | 3 | 2017 | 2235 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
cis-trans-Isomerases | 1 | 2018 | 45 | 0.160 |
Why?
|
Emollients | 1 | 2018 | 42 | 0.150 |
Why?
|
Computer Security | 7 | 1998 | 261 | 0.150 |
Why?
|
Antibodies, Bispecific | 1 | 2021 | 204 | 0.150 |
Why?
|
Massachusetts | 3 | 2022 | 8890 | 0.150 |
Why?
|
Hypoglycemic Agents | 2 | 2021 | 3109 | 0.150 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2020 | 328 | 0.150 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 453 | 0.150 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8052 | 0.140 |
Why?
|
Decision Making, Computer-Assisted | 2 | 1995 | 146 | 0.140 |
Why?
|
Clinical Protocols | 2 | 2014 | 1443 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 1 | 2020 | 462 | 0.140 |
Why?
|
Creatinine | 2 | 1994 | 1918 | 0.140 |
Why?
|
Hospital Information Systems | 9 | 1998 | 395 | 0.140 |
Why?
|
Alzheimer Disease | 3 | 2023 | 8759 | 0.130 |
Why?
|
Pyrazoles | 2 | 2024 | 2028 | 0.130 |
Why?
|
Minority Groups | 1 | 2023 | 1216 | 0.130 |
Why?
|
Schizophrenia | 2 | 2024 | 6983 | 0.120 |
Why?
|
Psychotherapy | 1 | 2024 | 1654 | 0.120 |
Why?
|
Internet | 3 | 2008 | 3110 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1065 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2021 | 1162 | 0.120 |
Why?
|
Clinical Medicine | 2 | 1993 | 145 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 2019 | 577 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1071 | 0.110 |
Why?
|
Clinical Laboratory Information Systems | 1 | 1994 | 108 | 0.110 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1183 | 0.110 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 590 | 0.110 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9262 | 0.110 |
Why?
|
Qualitative Research | 1 | 2024 | 3140 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1334 | 0.100 |
Why?
|
Attitude to Computers | 1 | 1993 | 196 | 0.100 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2023 | 1475 | 0.100 |
Why?
|
Cystic Fibrosis | 1 | 2021 | 1294 | 0.090 |
Why?
|
Quality Assurance, Health Care | 3 | 2013 | 2176 | 0.090 |
Why?
|
Advisory Committees | 2 | 2024 | 796 | 0.080 |
Why?
|
Biological Products | 1 | 2019 | 947 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2019 | 2167 | 0.080 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2015 | 522 | 0.080 |
Why?
|
Information Dissemination | 1 | 1997 | 1143 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 1178 | 0.080 |
Why?
|
Sample Size | 1 | 2011 | 846 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2020 | 1713 | 0.070 |
Why?
|
Obesity | 2 | 2023 | 13091 | 0.070 |
Why?
|
Human Rights | 1 | 1990 | 312 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6894 | 0.070 |
Why?
|
Germany | 2 | 2024 | 883 | 0.070 |
Why?
|
Medicare | 2 | 2024 | 6809 | 0.070 |
Why?
|
Health Care Costs | 2 | 2024 | 3239 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4206 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10397 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4640 | 0.070 |
Why?
|
Myocardial Infarction | 1 | 2007 | 11519 | 0.070 |
Why?
|
Health Personnel | 3 | 2016 | 3384 | 0.070 |
Why?
|
Medical Record Linkage | 3 | 1998 | 286 | 0.070 |
Why?
|
Information Systems | 1 | 2008 | 400 | 0.070 |
Why?
|
HIV Infections | 5 | 2007 | 17569 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5176 | 0.060 |
Why?
|
Observer Variation | 1 | 2011 | 2621 | 0.060 |
Why?
|
Markov Chains | 2 | 2018 | 979 | 0.060 |
Why?
|
Patients | 2 | 2005 | 908 | 0.060 |
Why?
|
Boston | 12 | 2003 | 9374 | 0.060 |
Why?
|
Health Policy | 3 | 2022 | 2697 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1742 | 0.060 |
Why?
|
Meta-Analysis as Topic | 2 | 2023 | 1363 | 0.050 |
Why?
|
Software Design | 3 | 1998 | 173 | 0.050 |
Why?
|
Risk | 3 | 2011 | 9613 | 0.050 |
Why?
|
Transaminases | 1 | 2003 | 199 | 0.050 |
Why?
|
Therapy, Computer-Assisted | 2 | 1996 | 265 | 0.050 |
Why?
|
Risperidone | 1 | 2024 | 383 | 0.050 |
Why?
|
Aged | 7 | 2023 | 171502 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 1994 | 1942 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26379 | 0.050 |
Why?
|
Rhode Island | 1 | 2022 | 352 | 0.050 |
Why?
|
Child, Preschool | 1 | 2024 | 42669 | 0.050 |
Why?
|
New England | 1 | 2024 | 1058 | 0.050 |
Why?
|
Ambulatory Care Information Systems | 2 | 1991 | 89 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.050 |
Why?
|
Creatine Kinase | 1 | 2003 | 684 | 0.050 |
Why?
|
Informed Consent | 2 | 1998 | 1010 | 0.050 |
Why?
|
Benzylamines | 1 | 2022 | 251 | 0.050 |
Why?
|
Uracil | 1 | 2022 | 210 | 0.040 |
Why?
|
Hospitals, Teaching | 4 | 1993 | 1157 | 0.040 |
Why?
|
Benzodioxoles | 1 | 2021 | 80 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2022 | 232 | 0.040 |
Why?
|
Child | 3 | 2024 | 80917 | 0.040 |
Why?
|
Aminophenols | 1 | 2021 | 94 | 0.040 |
Why?
|
Male | 13 | 2024 | 364731 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6316 | 0.040 |
Why?
|
Kidney Diseases | 1 | 1991 | 2100 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13677 | 0.040 |
Why?
|
Primary Health Care | 6 | 2005 | 4746 | 0.040 |
Why?
|
Hospitals | 2 | 2008 | 3886 | 0.040 |
Why?
|
Alanine | 1 | 2022 | 614 | 0.040 |
Why?
|
Medical Informatics Computing | 1 | 1998 | 23 | 0.040 |
Why?
|
Decision Support Techniques | 2 | 2024 | 2008 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 349 | 0.040 |
Why?
|
Pyridines | 2 | 2021 | 2894 | 0.040 |
Why?
|
Unified Medical Language System | 1 | 1998 | 89 | 0.040 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3252 | 0.040 |
Why?
|
Paper | 1 | 1998 | 83 | 0.040 |
Why?
|
Home Nursing | 1 | 1998 | 92 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 1997 | 7951 | 0.040 |
Why?
|
Quinolones | 1 | 2021 | 389 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2020 | 563 | 0.030 |
Why?
|
Age Factors | 2 | 2019 | 18415 | 0.030 |
Why?
|
Aminopyridines | 1 | 2021 | 580 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 687 | 0.030 |
Why?
|
Clinical Competence | 2 | 2012 | 4858 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2359 | 0.030 |
Why?
|
Female | 13 | 2023 | 397187 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2012 | 2923 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2019 | 1169 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2001 | 724 | 0.030 |
Why?
|
Adult | 9 | 2021 | 223646 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2022 | 1309 | 0.030 |
Why?
|
Warfarin | 1 | 2024 | 1493 | 0.030 |
Why?
|
Anticholesteremic Agents | 1 | 2003 | 972 | 0.030 |
Why?
|
Maryland | 1 | 1996 | 278 | 0.030 |
Why?
|
Quinolines | 1 | 2021 | 772 | 0.030 |
Why?
|
Prednisone | 1 | 2020 | 1567 | 0.030 |
Why?
|
Medical Records, Problem-Oriented | 1 | 1995 | 36 | 0.030 |
Why?
|
User-Computer Interface | 3 | 1997 | 1407 | 0.030 |
Why?
|
Hospital Records | 1 | 1995 | 93 | 0.030 |
Why?
|
Patient Advocacy | 1 | 1997 | 362 | 0.030 |
Why?
|
Expert Systems | 1 | 1995 | 79 | 0.030 |
Why?
|
Office Automation | 1 | 1994 | 14 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2001 | 392 | 0.030 |
Why?
|
Benzamides | 1 | 2020 | 1379 | 0.030 |
Why?
|
Crime | 1 | 1996 | 206 | 0.030 |
Why?
|
Social Responsibility | 1 | 1997 | 382 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2089 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2029 | 0.030 |
Why?
|
Pyrroles | 1 | 2020 | 1124 | 0.030 |
Why?
|
Software | 3 | 1998 | 4480 | 0.030 |
Why?
|
Exons | 1 | 2020 | 2394 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13668 | 0.030 |
Why?
|
Medical Records | 2 | 1998 | 1410 | 0.030 |
Why?
|
Information Storage and Retrieval | 2 | 1998 | 830 | 0.030 |
Why?
|
Internal Medicine | 1 | 2000 | 1064 | 0.030 |
Why?
|
Organizational Policy | 1 | 1995 | 435 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1836 | 0.030 |
Why?
|
Computers | 1 | 1995 | 592 | 0.030 |
Why?
|
Economic Competition | 1 | 1994 | 223 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4034 | 0.030 |
Why?
|
Hemorrhage | 1 | 2024 | 3466 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1667 | 0.020 |
Why?
|
Vision Disorders | 1 | 2018 | 1092 | 0.020 |
Why?
|
Medical History Taking | 1 | 1995 | 779 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15949 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15662 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 1998 | 1514 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4861 | 0.020 |
Why?
|
Aminoglycosides | 1 | 1991 | 161 | 0.020 |
Why?
|
Publication Bias | 1 | 2010 | 158 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1996 | 2204 | 0.020 |
Why?
|
Natural Language Processing | 1 | 1998 | 1203 | 0.020 |
Why?
|
Personal Health Services | 1 | 2008 | 24 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 60066 | 0.020 |
Why?
|
Anticoagulants | 1 | 2024 | 4850 | 0.020 |
Why?
|
Biomedical Technology | 1 | 2010 | 210 | 0.020 |
Why?
|
Research Design | 2 | 2013 | 6209 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 3251 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2001 | 3620 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 89169 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2130 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2012 | 1328 | 0.020 |
Why?
|
Interviews as Topic | 1 | 1995 | 2741 | 0.020 |
Why?
|
Information Services | 1 | 2008 | 239 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4754 | 0.020 |
Why?
|
Knowledge | 1 | 2008 | 178 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2661 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2008 | 445 | 0.020 |
Why?
|
Attitude of Health Personnel | 3 | 1995 | 3929 | 0.020 |
Why?
|
Attitude | 1 | 1990 | 772 | 0.020 |
Why?
|
Academic Medical Centers | 3 | 2001 | 2785 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1995 | 2709 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 3 | 1996 | 2596 | 0.010 |
Why?
|
Cost of Illness | 1 | 1994 | 1951 | 0.010 |
Why?
|
Middle Aged | 6 | 2021 | 223487 | 0.010 |
Why?
|
Linear Models | 1 | 1994 | 5884 | 0.010 |
Why?
|
Medical Audit | 1 | 2005 | 454 | 0.010 |
Why?
|
Patient Care Team | 1 | 1995 | 2523 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1991 | 1515 | 0.010 |
Why?
|
Artificial Intelligence | 2 | 1996 | 2666 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2016 | 4310 | 0.010 |
Why?
|
Physicians | 4 | 1995 | 4598 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1991 | 1798 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3968 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59626 | 0.010 |
Why?
|
Stroke | 1 | 2024 | 9755 | 0.010 |
Why?
|
Decision Making | 1 | 2016 | 3953 | 0.010 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1991 | 113 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 414 | 0.010 |
Why?
|
Time Factors | 2 | 2020 | 40220 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1991 | 2271 | 0.010 |
Why?
|
Palpation | 1 | 2000 | 166 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 2003 | 606 | 0.010 |
Why?
|
Prospective Studies | 3 | 1995 | 54924 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1998 | 5891 | 0.010 |
Why?
|
Pilot Projects | 2 | 2005 | 8741 | 0.010 |
Why?
|
Muscular Diseases | 1 | 2003 | 553 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2008 | 1805 | 0.010 |
Why?
|
Hospitalization | 2 | 1995 | 10840 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2001 | 540 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23648 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20225 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30237 | 0.010 |
Why?
|
Data Collection | 2 | 1996 | 3326 | 0.010 |
Why?
|
Systems Integration | 1 | 1998 | 430 | 0.010 |
Why?
|
Organizational Objectives | 1 | 1998 | 426 | 0.010 |
Why?
|
Computer Literacy | 1 | 1995 | 44 | 0.010 |
Why?
|
Vocabulary, Controlled | 1 | 1996 | 170 | 0.010 |
Why?
|
Methods | 1 | 1995 | 1066 | 0.010 |
Why?
|
Semantics | 1 | 1998 | 618 | 0.010 |
Why?
|
Length of Stay | 1 | 2008 | 6498 | 0.010 |
Why?
|
Health Planning | 1 | 1996 | 233 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2008 | 5349 | 0.010 |
Why?
|
Famous Persons | 1 | 1995 | 109 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2000 | 21207 | 0.010 |
Why?
|
Zidovudine | 1 | 1995 | 625 | 0.010 |
Why?
|
Family Practice | 1 | 1995 | 509 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1991 | 7477 | 0.010 |
Why?
|
Policy Making | 1 | 1996 | 546 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24318 | 0.010 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1995 | 664 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 1997 | 1397 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2430 | 0.010 |
Why?
|
Mammography | 1 | 2000 | 2433 | 0.010 |
Why?
|
Disclosure | 1 | 1995 | 755 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1995 | 2862 | 0.000 |
Why?
|
Interprofessional Relations | 1 | 1995 | 997 | 0.000 |
Why?
|
Employment | 1 | 1995 | 1110 | 0.000 |
Why?
|
Retrospective Studies | 3 | 2003 | 81760 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2005 | 22290 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7578 | 0.000 |
Why?
|
Sex Factors | 1 | 2000 | 10632 | 0.000 |
Why?
|
Regression Analysis | 1 | 1995 | 6340 | 0.000 |
Why?
|
Comorbidity | 1 | 2000 | 10590 | 0.000 |
Why?
|
Nurses | 1 | 1995 | 2501 | 0.000 |
Why?
|
Physician-Patient Relations | 1 | 1998 | 3269 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1995 | 2783 | 0.000 |
Why?
|
Emergency Medical Services | 1 | 1995 | 1947 | 0.000 |
Why?
|
Communication | 1 | 1998 | 3905 | 0.000 |
Why?
|
Cohort Studies | 1 | 2005 | 41753 | 0.000 |
Why?
|
Antiviral Agents | 1 | 1995 | 3072 | 0.000 |
Why?
|
Survival Rate | 1 | 1995 | 12840 | 0.000 |
Why?
|
Telemedicine | 1 | 1998 | 3109 | 0.000 |
Why?
|
Risk Factors | 1 | 1996 | 74944 | 0.000 |
Why?
|